Published in Curr Opin Urol on July 01, 2006
Transvaginal adjustable tape: an adjustable mesh for surgical treatment of female stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct (2008) 0.87
Urinary incontinence in the CKiD cohort and health related quality of life. J Urol (2009) 0.83
The Portuguese validation of the International Consultation on Incontinence Questionnaire-Vaginal Symptoms (ICIQ-VS) for Brazilian women with pelvic organ prolapse. Int Urogynecol J Pelvic Floor Dysfunct (2008) 0.82
Subjective versus objective measurement of surgical outcomes of treatment of female stress urinary incontinence: it is not just black and white. Int Urogynecol J (2010) 0.81
Three-year outcomes of Uretex Urethral Support System for treatment of stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct (2008) 0.75
Contasure-needleless® compared with Monarc® for the treatment of stress urinary incontinence. Int Urogynecol J (2016) 0.75
Change in urinary storage symptoms following treatment for female stress urinary incontinence. Int Urogynecol J (2016) 0.75
Efficacy and safety of onabotulinumtoxinA for idiopathic overactive bladder: a double-blind, placebo controlled, randomized, dose ranging trial. J Urol (2010) 2.68
Artificial urinary sphincter revision: the role of ultrasound. Urology (2013) 2.62
Contemporary management of postprostatectomy incontinence. Eur Urol (2011) 2.01
An artificial somatic-central nervous system-autonomic reflex pathway for controllable micturition after spinal cord injury: preliminary results in 15 patients. J Urol (2003) 1.73
Managing the urethra at transvaginal pelvic organ prolapse repair: a urodynamic approach. J Urol (2008) 1.67
Urodynamic studies in adults: AUA/SUFU guideline. J Urol (2012) 1.51
Pressure flow urodynamic studies: the gold standard for diagnosing bladder outlet obstruction. Rev Urol (2005) 1.49
Artificial urinary sphincter versus male sling for post-prostatectomy incontinence--what do patients choose? J Urol (2009) 1.30
American Urological Association Symptom Index for lower urinary tract symptoms in women: correlation with degree of bother and impact on quality of life. Urology (2003) 1.30
Mirabegron in overactive bladder: a review of efficacy, safety, and tolerability. Neurourol Urodyn (2013) 1.17
Comparison of diagnostic criteria for female bladder outlet obstruction. J Urol (2006) 1.14
Efficacy and safety of extended-release oxybutynin in combination with tamsulosin for treatment of lower urinary tract symptoms in men: randomized, double-blind, placebo-controlled study. Mayo Clin Proc (2008) 1.11
Review article: Mid-urethral synthetic slings for female stress urinary incontinence. BJU Int (2010) 1.10
Female urethral reconstruction. Urol Clin North Am (2011) 1.01
The male perineal sling: assessment and prediction of outcome. J Urol (2007) 0.95
Surgical management of Skene's gland abscess/infection: a contemporary series. Int Urogynecol J (2011) 0.95
Effect of tension-free vaginal tape and TVT-obturator on lower urinary tract symptoms other than stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct (2007) 0.94
A urodynamics protocol to optimally assess men with post-prostatectomy incontinence. Neurourol Urodyn (2005) 0.90
Primary bladder neck obstruction in men and women. Rev Urol (2005) 0.90
Botulinum toxin for the treatment of idiopathic and neurogenic overactive bladder: state of the art. Rev Urol (2006) 0.90
Urinary incontinence. Prim Care (2010) 0.88
Pubovaginal sling and pelvic prolapse repair in women with occult stress urinary incontinence: effect on postoperative emptying and voiding symptoms. Urology (2002) 0.87
Validation of a bladder symptom screening tool in women with incontinence due to overactive bladder. Int Urogynecol J (2014) 0.87
Treatment of post-prostatectomy incontinence with male slings in patients with impaired detrusor contractility on urodynamics and/or who perform Valsalva voiding. J Urol (2011) 0.87
Patient perception of videourodynamic testing: a questionnaire based study. J Urol (2005) 0.86
Clinical impact of overactive bladder. Rev Urol (2002) 0.85
Midurethral slings for all stress incontinence: a urology perspective. Urol Clin North Am (2012) 0.85
Management of recurrent urinary tract infections in healthy adult women. Rev Urol (2013) 0.84
Repeat urethrolysis after failed urethrolysis for iatrogenic obstruction. J Urol (2003) 0.84
Defining efficacy in the treatment of overactive bladder syndrome. Rev Urol (2009) 0.84
Degree of bother caused by nocturia in women. Neurourol Urodyn (2004) 0.83
Management of obstructive voiding dysfunction after incontinence surgery: lessons learned. Urology (2003) 0.83
Outcomes of patients lost to followup after mid urethral synthetic slings--successes or failures? J Urol (2010) 0.81
Efficacy and tolerability of fesoterodine in women with overactive bladder. Int Urogynecol J Pelvic Floor Dysfunct (2009) 0.81
Bladder-health diaries: an assessment of 3-day vs 7-day entries. BJU Int (2005) 0.81
Urodynamic differences between dysfunctional voiding and primary bladder neck obstruction in women. Urology (2012) 0.80
Recent advances in management of female lower urinary tract trauma. Curr Opin Urol (2003) 0.80
Primary bladder neck obstruction in men, women, and children. Curr Urol Rep (2007) 0.80
Duloxetine: a new pharmacologic therapy for stress urinary incontinence. Rev Urol (2004) 0.79
Voiding dysfunction in young, nulliparous women: symptoms and urodynamic findings. Int Urogynecol J Pelvic Floor Dysfunct (2004) 0.78
Long-term continence after surgery--what can we tell patients? J Urol (2012) 0.78
Tolterodine extended release is efficacious in continent and incontinent subjects with overactive bladder. Urology (2008) 0.78
Diagnosis and treatment of primary bladder neck obstruction in men. Curr Urol Rep (2005) 0.77
Comparison of urodynamic findings in women with anatomical versus functional bladder outlet obstruction. Female Pelvic Med Reconstr Surg (2013) 0.77
Onset of action of the β3-adrenoceptor agonist, mirabegron, in Phase II and III clinical trials in patients with overactive bladder. World J Urol (2014) 0.77
Can noninvasive evaluation of benign prostatic obstruction be optimized? Curr Opin Urol (2012) 0.77
Correlation of abdominal leak point pressure with objective incontinence severity in men with post-radical prostatectomy stress incontinence. Neurourol Urodyn (2005) 0.76
Tolterodine for treatment of overactive bladder. Urol Clin North Am (2006) 0.76
Endoscopic evacuation of Durasphere. Urology (2003) 0.76
Transdermal therapy for overactive bladder: present and future. Rev Urol (2003) 0.75
Is There a Role for alpha-Blockers for the Treatment of Voiding Dysfunction Unrelated to Benign Prostatic Hyperplasia? Rev Urol (2005) 0.75
Reply: To PMID 24295256. Urology (2013) 0.75
Urodynamics for clinically suspected obstruction after anti-incontinence surgery in women. J Urol (2013) 0.75
Editorial comment. Urology (2011) 0.75
Editorial comment. Urology (2011) 0.75
Urodynamic findings in women with insensible incontinence. Int J Urol (2012) 0.75
Pelvic floor reconstruction: state-of-the-art and beyond. Urol Clin North Am (2004) 0.75
Association between detrusor overactivity and postoperative outcomes in patients undergoing male bone anchored perineal sling. J Urol (2009) 0.75
Fistulization between ectopic ureteral stump and uterus following nephroureterectomy: case report. Int Urogynecol J Pelvic Floor Dysfunct (2009) 0.75
Vaginal granulation tissue secondary to bone anchors: experience in two patients. J Urol (2003) 0.75
Management of urinary retention and obstruction following surgery for stress urinary incontinence. Curr Urol Rep (2002) 0.75